Concepedia

Author

Derek Tang

Bristol-Myers Squibb (United States)

Also Known As

Azim Ansari, Derek H Tang, Derek H. Tang, Derek Tang, Tang, Derek

124

Publications

1.3K

Citations

22

H-Index

37

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Novartis (United States)University of ArizonaAmgen (United States)Ithaka Harbors
DT

About

Derek Tang is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacotherapy, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

169

2

Public Health

2

2

54

3

Health Sciences

1

1

23

4

Anesthesia

1

1

39

5

Epidemiology

1

1

17

Derek Tang

×

34

Publications

965

Citations

19

H-Index

YearCitations

Impact of urinary incontinence on healthcare resource utilization, health‐related quality of life and productivity in patients with overactive bladder

Derek Tang, Danielle Colayco, Kristin Khalaf,

British Journal of Urology

2013

98

Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective

Rohit Mistry, J. May, Gaurav Suri,

Journal of Managed Care & Specialty Pharmacy

2018

84

Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity

Derek Tang, Danielle Colayco, James Piercy,

BMC Neurology

2014

58

Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis

Brian C. Sauer, Chia‐Chen Teng, Derek Tang,

Arthritis Care & Research

2016

44

A Network Meta-Analysis on the Efficacy of Serotonin Type 3 Receptor Antagonists Used in Adults During the First 24 Hours for Postoperative Nausea and Vomiting Prophylaxis

Derek Tang, Daniel C. Malone

Clinical Therapeutics

2012

39

A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients

Benjamin Chastek, John White, Damon Van Voorhis,

Advances in Therapy

2016

39

Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study

Tao Gu, Neel Shah, Gaurav Deshpande,

Drugs - Real World Outcomes

2016

38

Economic Burden and Disparities in Healthcare Resource Use Among Adult Patients with Cardiac Arrhythmia

Derek Tang, Adrienne M. Gilligan, Klaus Romero

Applied Health Economics and Health Policy

2013

37

Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis

Machaon Bonafede, Barbara H. Johnson, Derek Tang,

Arthritis Care & Research

2015

37

Predictors of systemic therapy sequences following a CDK 4/6 inhibitor-based regimen in post-menopausal women with hormone receptor positive, HEGFR-2 negative metastatic breast cancer

Nicole Princic, Ayal A. Aizer, Derek Tang,

Current Medical Research and Opinion

2018

37

Page 1